Skip to main content
Clinical Trials/NCT04827316
NCT04827316
Recruiting
Not Applicable

Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)

Insel Gruppe AG, University Hospital Bern1 site in 1 country4,200 target enrollmentStarted: June 1, 2017Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
4,200
Locations
1
Primary Endpoint
All-cause death.

Overview

Brief Summary

In this study the investigators retrospectively and prospectively collect information from enrolled subjects undergoing CCTA and evaluate the association of cardiac and non-cardiac imaging with laboratory markers and clinical data including outcome.

Detailed Description

In this study the investigators retrospectively and prospectively collect information from enrolled subjects through a period of a total of 10 years to evaluate multidimensional associations between phenotypic manifestations of cardiovascular disease via CCTA and cardiac and non-cardiac imaging, serum biomarkers, demographic and clinical information, clinical presentation (cross-sectional), therapy changes (time-varying) and their ability to predict mortality and MACE (major adverse cardiac event ) (longitudinal) in patients clinically indicated for CCTA.

The aim is to establish a comprehensive cross-sectional, time-varying and longitudinal data collection for individuals undergoing clinically-indicated CCTA to date in order to apply novel multiparametric approaches to determine cardiovascular significance to clinically-important patient-centered events. For data collection this registry will follow a standard CRF (case report form) structure, so to enable the merging of this data-set with other international registries, which might contribute in overcoming some gaps of knowledge from previous CCTA studies.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult individual \>18 years
  • Undergoing clinically indicated CCTA
  • Signed informed consent or waiver

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

All-cause death.

Time Frame: 10 years

The primary endpoint is the time to first occurrence of death from all-causes.

Secondary Outcomes

  • Other outcome(10 years)
  • Major adverse cardiovascular events (MACE)(10 years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials